NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Clover Health Triumphs in Court – Massive 4.5-Star Medicare Rating Upgrade

Clover Health got its Medicare rating raised to 4.5 stars, boosting future government bonus payments from 2027.

Clover Health Triumphs in Court – Massive 4.5-Star Medicare Rating Upgrade
cloverhealth.com
Already have an account? Sign in.
06/10/2026 · 10:00 AM
CLOV
/ Don’t stop at just one post.

Related↓

Trump Administration Proposes Near-Flat Medicare Advantage Rates, Disappointing Insurers
Featured/ 01/26/2026 · 5:05 PM

Trump Administration Proposes Near-Flat Medicare Advantage Rates, Disappointing Insurers

Trump's CMS proposes minimal 0.09% Medicare payment increase for 2027, far below Wall Street's 4-6% expectations, while eliminating controversial billing practices.

/ Subscriber only
/ Read more

Feed↓

Chardan Slaps “Buy” Rating on CAMP4 Therapeutics – $6.50 Price Target Signals 60%+ Upside
06/10/2026 · 11:40 AM

Chardan Slaps “Buy” Rating on CAMP4 Therapeutics – $6.50 Price Target Signals 60%+ Upside

Its new gene-boosting drug shows promise for rare brain disorders with no treatments yet.

/ Subscriber only
Robinhood Just Got Approved as an IPO Underwriter — Here’s Why It’s a Game-Changer for Retail Investors
06/10/2026 · 10:33 AM

Robinhood Just Got Approved as an IPO Underwriter — Here’s Why It’s a Game-Changer for Retail Investors

CEO Vlad Tenev says the move will disrupt Wall Street and give retail investors bigger access to hot IPOs like SpaceX.

/ Subscriber only
B. Riley Sees Multi-Billion Dollar Potential in Elicio’s mKRAS Vaccine
Featured/ 06/10/2026 · 10:10 AM

B. Riley Sees Multi-Billion Dollar Potential in Elicio’s mKRAS Vaccine

B. Riley sees Elicio as a strong Buy; mKRAS cancer vaccine data in June could be a major stock catalyst.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe